Free Trial
→ You’re Being LIED To About The Iran War (From Banyan Hill Publishing) (Ad)tc pixel Free CUPR Stock Alerts

Cuprina Holdings (Cayman) (CUPR) Competitors

Cuprina Holdings (Cayman) logo
$0.27 +0.00 (+1.84%)
Closing price 04:00 PM Eastern
Extended Trading
$0.27 0.00 (0.00%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

CUPR vs. CPHI, NEUP, MRKR, TPST, and TXMD

Should you be buying Cuprina Holdings (Cayman) stock or one of its competitors? The main competitors of Cuprina Holdings (Cayman) include China Pharma (CPHI), Neuphoria Therapeutics (NEUP), Marker Therapeutics (MRKR), Tempest Therapeutics (TPST), and TherapeuticsMD (TXMD). These companies are all part of the "pharmaceutical products" industry.

How does Cuprina Holdings (Cayman) compare to China Pharma?

Cuprina Holdings (Cayman) (NASDAQ:CUPR) and China Pharma (NYSE:CPHI) are both small-cap pharmaceutical preparations industry companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cuprina Holdings (Cayman)
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
China Pharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

China Pharma has higher revenue and earnings than Cuprina Holdings (Cayman).

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cuprina Holdings (Cayman)$40K139.65-$3.63MN/AN/A
China Pharma$4.14M5.23-$3.08M-$0.75N/A

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to China Pharma's net margin of -85.56%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat China Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Cuprina Holdings (Cayman)N/A N/A N/A
China Pharma -85.56%-63.93%-31.42%

In the previous week, Cuprina Holdings (Cayman)'s average media sentiment score of 0.00 equaled China Pharma'saverage media sentiment score.

Company Overall Sentiment
Cuprina Holdings (Cayman) Neutral
China Pharma Neutral

Summary

Cuprina Holdings (Cayman) beats China Pharma on 5 of the 7 factors compared between the two stocks.

How does Cuprina Holdings (Cayman) compare to Neuphoria Therapeutics?

Neuphoria Therapeutics (NASDAQ:NEUP) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

Neuphoria Therapeutics currently has a consensus target price of $21.00, indicating a potential upside of 289.61%. Given Neuphoria Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Neuphoria Therapeutics is more favorable than Cuprina Holdings (Cayman).

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neuphoria Therapeutics
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Cuprina Holdings (Cayman)
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

15.9% of Neuphoria Therapeutics shares are owned by institutional investors. 1.5% of Neuphoria Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Neuphoria Therapeutics has higher revenue and earnings than Cuprina Holdings (Cayman).

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neuphoria Therapeutics$15.65M1.86-$370K-$4.42N/A
Cuprina Holdings (Cayman)$40K139.65-$3.63MN/AN/A

Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Neuphoria Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Neuphoria TherapeuticsN/A -25.98% -18.39%
Cuprina Holdings (Cayman) N/A N/A N/A

In the previous week, Neuphoria Therapeutics had 1 more articles in the media than Cuprina Holdings (Cayman). MarketBeat recorded 1 mentions for Neuphoria Therapeutics and 0 mentions for Cuprina Holdings (Cayman). Neuphoria Therapeutics' average media sentiment score of 0.00 equaled Cuprina Holdings (Cayman)'saverage media sentiment score.

Company Overall Sentiment
Neuphoria Therapeutics Neutral
Cuprina Holdings (Cayman) Neutral

Summary

Neuphoria Therapeutics beats Cuprina Holdings (Cayman) on 8 of the 11 factors compared between the two stocks.

How does Cuprina Holdings (Cayman) compare to Marker Therapeutics?

Marker Therapeutics (NASDAQ:MRKR) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Marker Therapeutics' net margin of -343.03%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Marker Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Marker Therapeutics-343.03% -80.86% -67.04%
Cuprina Holdings (Cayman) N/A N/A N/A

In the previous week, Marker Therapeutics' average media sentiment score of 0.00 equaled Cuprina Holdings (Cayman)'saverage media sentiment score.

Company Overall Sentiment
Marker Therapeutics Neutral
Cuprina Holdings (Cayman) Neutral

Marker Therapeutics currently has a consensus target price of $10.00, indicating a potential upside of 562.25%. Given Marker Therapeutics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Marker Therapeutics is more favorable than Cuprina Holdings (Cayman).

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Marker Therapeutics
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Cuprina Holdings (Cayman)
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

22.4% of Marker Therapeutics shares are owned by institutional investors. 5.7% of Marker Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Marker Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marker Therapeutics$3.55M7.09-$12.16M-$0.85N/A
Cuprina Holdings (Cayman)$40K139.65-$3.63MN/AN/A

Summary

Marker Therapeutics beats Cuprina Holdings (Cayman) on 6 of the 11 factors compared between the two stocks.

How does Cuprina Holdings (Cayman) compare to Tempest Therapeutics?

Tempest Therapeutics (NASDAQ:TPST) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Tempest Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Tempest TherapeuticsN/A -309.60% -115.81%
Cuprina Holdings (Cayman) N/A N/A N/A

In the previous week, Tempest Therapeutics had 1 more articles in the media than Cuprina Holdings (Cayman). MarketBeat recorded 1 mentions for Tempest Therapeutics and 0 mentions for Cuprina Holdings (Cayman). Tempest Therapeutics' average media sentiment score of 0.00 equaled Cuprina Holdings (Cayman)'saverage media sentiment score.

Company Overall Sentiment
Tempest Therapeutics Neutral
Cuprina Holdings (Cayman) Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tempest Therapeutics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50
Cuprina Holdings (Cayman)
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

22.5% of Tempest Therapeutics shares are owned by institutional investors. 6.3% of Tempest Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cuprina Holdings (Cayman) has higher revenue and earnings than Tempest Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tempest TherapeuticsN/AN/A-$26.26M-$6.64N/A
Cuprina Holdings (Cayman)$40K139.65-$3.63MN/AN/A

Summary

Tempest Therapeutics beats Cuprina Holdings (Cayman) on 5 of the 9 factors compared between the two stocks.

How does Cuprina Holdings (Cayman) compare to TherapeuticsMD?

TherapeuticsMD (NASDAQ:TXMD) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability.

TherapeuticsMD has higher revenue and earnings than Cuprina Holdings (Cayman).

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TherapeuticsMD$3.02M7.93-$570K-$0.01N/A
Cuprina Holdings (Cayman)$40K139.65-$3.63MN/AN/A

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to TherapeuticsMD's net margin of -18.83%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat TherapeuticsMD's return on equity.

Company Net Margins Return on Equity Return on Assets
TherapeuticsMD-18.83% -2.41% -1.71%
Cuprina Holdings (Cayman) N/A N/A N/A

In the previous week, TherapeuticsMD's average media sentiment score of 0.00 equaled Cuprina Holdings (Cayman)'saverage media sentiment score.

Company Overall Sentiment
TherapeuticsMD Neutral
Cuprina Holdings (Cayman) Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TherapeuticsMD
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Cuprina Holdings (Cayman)
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

30.7% of TherapeuticsMD shares are owned by institutional investors. 1.7% of TherapeuticsMD shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

TherapeuticsMD and Cuprina Holdings (Cayman) tied by winning 4 of the 8 factors compared between the two stocks.

Get Cuprina Holdings (Cayman) News Delivered to You Automatically

Sign up to receive the latest news and ratings for CUPR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CUPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CUPR vs. The Competition

Export
MetricCuprina Holdings (Cayman)Pharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market Cap$5.49M$886.55M$4.22B$11.77B
Dividend YieldN/A4.84%5.87%5.26%
P/E RatioN/A1.7123.3727.07
Price / Sales139.65120.63162.1275.42
Price / CashN/A20.0752.0853.90
Price / Book1.407.6037.876.69
Net Income-$3.63M-$4.80M$114.66M$332.64M
7 Day Performance-6.54%-0.05%1.21%2.01%
1 Month Performance-21.53%5.50%5.50%9.19%
1 Year PerformanceN/A30.96%18.68%39.59%

Cuprina Holdings (Cayman) Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CUPR
Cuprina Holdings (Cayman)
N/A$0.27
+1.8%		N/AN/A$5.49M$40KN/A14
CPHI
China Pharma
N/A$0.65
-1.2%		N/AN/A$26.26M$4.14MN/A250
NEUP
Neuphoria Therapeutics
2.2161 of 5 stars		$4.93
+1.2%		$21.00
+326.0%		N/A$26.25M$15.65MN/AN/A
MRKR
Marker Therapeutics
1.9029 of 5 stars		$1.54
-1.3%		$10.00
+549.4%		N/A$26.01M$3.55MN/A60
TPST
Tempest Therapeutics
0.7523 of 5 stars		$1.85
+4.5%		N/AN/A$25.39MN/AN/A20

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CUPR) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel